Date | Title | Description | Source |
28.10.2021 | GEN-011 neoantigen-targeted peripheral T cell therapy clinic... | GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues
Strong presence at t... | marketscre... |
29.07.2021 | Genocea Biosciences : Provides Second Quarter 2021 Corporate... | GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues
GEN-009 neoantigen v... | marketscre... |
29.04.2021 | GENOCEA BIOSCIENCES, INC.
Genocea Biosciences : Provides Fi... | GEN-011 and GEN-009 immuno-oncology programs continue to advance
Research on Inhibigens™ and SARS-C... | marketscre... |
29.04.2021 | GENOCEA BIOSCIENCES, INC.
GEN-011 and GEN-009 immuno-oncolo... | GEN-011 and GEN-009 immuno-oncology programs continue to advance
Research on Inhibigens™ and SARS-C... | marketscre... |
30.07.2020 | Bristol Myers Squibb and bluebird bio return to FDA; Tak... | More than two months after the FDA slammed Bristol Myers Squibb and bluebird bio with a suprise ... | endpts.com... |
14.12.2018 | Shinichi Tamura reclaims the throne at Sosei; Jeff Abbey ... | → Jeff Abbey is jumping to the helm of Belgium’s Novadip Biosciences after leading Argos Ther... | endpts.com... |
29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
12.02.2015 | Will the $350M fund Lux Capital is raising include digital h... | HIPAA compliance
Aptible automates HIPAA compliance for Web-based and mobile applications. It manag... | medcitynew... |
24.12.2014 | Our 5 most popular biotech and pharma stories of 2014 | This story was actually the most viewed story of the year.
“After decades of stagnancy in the herpe... | medcitynew... |
15.10.2014 | Herpes vaccine maker Genocea reports positive results a year... | “They had gone with what works: Taken what they thought were targets that B cells would recognize, a... | medcitynew... |
03.10.2014 | Race tight for genital herpes vaccine | The tight competition’s indicative of a lucrative market. Herpes, a chronic viral infection, impacts... | medcitynew... |
04.10.2013 | From gamification to personalized medicine, here’s a list of... | CardioReady (@CardioReady) is all about automated external defibrillators and helps customers evalua... | medcitynew... |
11.10.2012 | Startup developing herpes, malaria vaccines raises $30M from... | Location: Cambridge, Massachusetts.
Solution/product: The biotech startup has a proprietary technol... | medcitynew... |
10.10.2012 | Genocea Closes $30M in Series C |
CAMBRIDGE, MA, Clinical-stage company advancing innovative T cell vaccines for infectious diseases... | vcnewsdail... |
10.10.2012 | Genocea Closes $30 Million in Series C Financing | - | jnjinnovat... |
10.10.2012 | Genocea Biosciences Raises $30M in Series C | Genocea Biosciences, Inc., a Cambridge, Mass.-based clinical-stage company advancing innovative T ce... | finsmes.co... |
10.10.2012 | Genocea Closes $30 Million in Series C Financing. The Bill &... | - | mp-healthc... |
03.01.2011 | Genocea Biosciences Closes $35 Million Series B Financing | - | jnjinnovat... |
03.01.2011 | Genocea Biosciences Closes $35 Million Series B Financing. | - | mp-healthc... |
03.01.2011 | Genocea Biosciences Closes $35M Series B Financing Round | Genocea Biosciences, Inc., a Cambridge, MA-based developer of a new class of T cell-based vaccines, ... | finsmes.co... |
09.07.2008 | Genocea Teams With Nonprofit PATH on Vaccine for Children in... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Genocea Biosciences is aiming to u... | xconomy.co... |
- | Neoantigens: Friend or foe? New insights into tumor mutation... | Identification and optimization of the best tumor antigens has been a consistent focus for cancer im... | statnews.c... |
- | From gamification to personalized medicine, here’s a list of... | Identifying and tracking patients who are likely to be readmitted, gamification strategies for emplo... | medcitynew... |
- | Herpes vaccine maker Genocea reports positive results a year... | Cambridge pharmaceutical maker Genocea remains at the head of the herpes vaccine pack, having newly ... | medcitynew... |
- | Our 5 most popular biotech and pharma stories of 2014 | Sometimes it’s difficult to tell if a story is going to be wildly popular or just barely make a spla... | medcitynew... |
- | Will the $350M fund Lux Capital is raising include digital h... | Lux Capital is raising a $350 million fund, Lux Ventures 4, as Fierce Biotech has already noted. Fro... | medcitynew... |
- | Race tight for genital herpes vaccine | After decades of stagnancy in the herpes therapeutics space, a real neck-and-neck race is emerging a... | medcitynew... |
- | Startup developing herpes, malaria vaccines raises $30M from... | Company name: Genocea Biosciences Inc.
Industry: Biotechnology.
Location: Cambridge, Massachusetts... | medcitynew... |